Us2.ai AI Echocardiography Platform

Us2.ai is a Singapore-based company (office at 72 Circular Road, Singapore) that builds AI software for echocardiography, aiming to cut the time and operator dependence of cardiac ultrasound measurement and reporting.

The platform takes standard DICOM 2D echo studies from any vendor's cart or handheld ultrasound, automatically measures chambers, valves, Doppler and strain, and produces a structured report that the cardiologist reviews and signs. Modules cover heart failure, aortic stenosis, pulmonary hypertension, cardiac amyloidosis and stress echo. It can run in the cloud or on-premise, including air-gapped sites.

• Automated measurements: Measures chambers, valves, Doppler and strain from standard 2D echo studies.
• Disease detection: Flags cardiac amyloidosis and supports heart failure, aortic stenosis and pulmonary hypertension workflows.
• Structured reporting: Generates reports that the cardiologist reviews, edits and signs.
• Vendor-neutral DICOM routing: Connects to PACS, CVIS and EMR/EHR systems.
• Flexible deployment: Runs in the cloud or on-premise, including air-gapped sites.
• Handheld support: Analyzes studies from point-of-care ultrasound devices.

Cardiovascular imaging units in Vietnamese general hospitals can speed up echo reporting. Health-check centers can screen for heart failure with handheld echo. Cardiac research cores can standardize measurements across multi-site studies.

Shortens echo reading: a Ho Chi Minh City hospital reported diagnosis time falling from 35-40 minutes to about 10 minutes per study.

Vendor-neutral, so existing GE, Philips, Siemens, Canon or handheld devices can be reused.

Provides consistent, structured measurements that support standardized reports across sonographers.

Offers cloud or on-premise deployment to match hospital data policies.

Cardiology departments face growing echo volumes and a shortage of trained sonographers. AI-assisted echo is gaining regulatory clearances worldwide, and handheld ultrasound is spreading into primary care. In Vietnam and Southeast Asia, large public hospitals are early adopters, as the 2025 Ho Chi Minh City deployment shows.

Singapore-based; footer lists a Singapore UEN and a UK ICO registration. Cleared in 28+ markets per its FAQ (FDA 510(k), CE MDR, MHRA, TGA, Health Canada, PMDA, HSA). Reseller agreement with Canon Medical Systems USA announced in 2026. Partners include Fujifilm, GE HealthCare and Microsoft.